{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Toxoplasma gondii RH strain", "Toxoplasma gondii Tehran strain", "blood-brain barrier", "curcumin nanoemulsion", "curcumin suspension", "soybean oil", "spontaneous emulsification"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30519020", "DateCompleted": {"Year": "2019", "Month": "01", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "05", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "11", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.2147/IJN.S181896"], "Journal": {"ISSN": "1178-2013", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2018"}}, "Title": "International journal of nanomedicine", "ISOAbbreviation": "Int J Nanomedicine"}, "ArticleTitle": "Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice.", "Pagination": {"StartPage": "7363", "EndPage": "7374", "MedlinePgn": "7363-7374"}, "Abstract": {"AbstractText": ["The aim of this study was to prepare curcumin nanoemulsion (CR-NE) to solve the problems associated with poor water solubility and low bioavailability of CR and to test its efficiency in the treatment of acute and chronic toxoplasmosis in mouse models.", "CR-NE 1% was prepared using spontaneous emulsification by soybean as oil phase; a mixture of Tween 80 and Tween 85 as surfactant; ethanol as cosurfactant and distilled water. Particle size and zeta potential of NE were assessed using Nano-ZS90 dynamic light scattering. Stability testing of NE was assessed after storage for 2 months at room temperature. In vivo experiments were carried out using 50 BALB/c mice inoculated with virulent RH strain (type I) and 50 BALB/c mice inoculated with avirulent Tehran strain (type II) of <i>Toxoplasma gondii</i> and treated with CR-NE (1% w/v), CR suspension (CR-S, 1% w/v), and NE without CR (NE-no CR).", "The mean particle size and zeta potential of CR-NE included 215.66\u00b116.8 nm and -29.46\u00b12.65 mV, respectively, and were stable in particle size after a three freeze-thaw cycle. In acute phase experiment, the survival time of mice infected with RH strain of <i>T. gondii</i> and treated with CR-NE extended from 8 to 10 days postinoculation. The differences were statistically significant between the survival time of mice in CR-NE-treated group compared with negative control group (<i>P</i><0.001). Furthermore, CR-NE significantly decreased the mean counts of peritoneum tachyzoites from 5,962.5\u00b1666 in negative control group to 627.5\u00b173 in CR-NE-treated mice (<i>P</i><0.001). Growth inhibition rates of tachyzoites in peritoneum of mice receiving CR-NE, CR-S, and NE-no CR included 90%, 21%, and 11%, respectively, compared with negative control group. In chronic phase experiment, the average number and size of tissue cysts significantly decreased to 17.2\u00b115.6 and 31.5\u00b16.26 \u00b5m, respectively, in mice inoculated with bradyzoites of <i>T. gondii</i> Tehran strain and treated with CR-NE compared with that in negative control group (<i>P</i><0.001). Decrease of cyst numbers was verified by downregulation of BAG1 in treatment groups compared with negative control group with a minimum relative expression in CR-NE (1.12\u00b10.28), CR-S (11.76\u00b10.87), and NE-no CR (14.67\u00b10.77), respectively, (<i>P</i><0.001).", "Results from the current study showed the potential of CR-S and CR-NE in treatment of acute and chronic toxoplasmosis in mouse models for the first time. However, CR-NE was more efficient than CR-S, and it seems that CR-NE has a potential formula for the treatment of acute and chronic toxoplasmosis, especially in those with latent bradyzoites in brain."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, shojaee1980@yahoo.com."}], "LastName": "Azami", "ForeName": "Sanaz Jafarpour", "Initials": "SJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, shojaee1980@yahoo.com."}, {"Identifier": [], "Affiliation": "Students Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Teimouri", "ForeName": "Aref", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, shojaee1980@yahoo.com."}], "LastName": "Keshavarz", "ForeName": "Hossein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Amani", "ForeName": "Amir", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Esmaeili", "ForeName": "Fariba", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, shojaee1980@yahoo.com."}, {"Identifier": [], "Affiliation": "Department of Medical Parasitology and Mycology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran."}], "LastName": "Hasanpour", "ForeName": "Hamid", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, shojaee1980@yahoo.com."}], "LastName": "Elikaee", "ForeName": "Samira", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Public Health, School of Health, Zabol University of Medical Sciences, Zabol, Iran."}], "LastName": "Salehiniya", "ForeName": "Hamid", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, shojaee1980@yahoo.com."}], "LastName": "Shojaee", "ForeName": "Saeedeh", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Int J Nanomedicine", "NlmUniqueID": "101263847", "ISSNLinking": "1176-9114"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Emulsions"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Acute Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pathology"], "DescriptorName": "Brain"}, {"QualifierName": [], "DescriptorName": "Chronic Disease"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Emulsions"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nanoparticles"}, {"QualifierName": [], "DescriptorName": "Toxicity Tests"}, {"QualifierName": ["growth & development"], "DescriptorName": "Toxoplasma"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Toxoplasmosis"}], "CoiStatement": "Disclosure The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Dubey JP. Toxoplasmosis of Animals and Humans. 2nd ed. Boca Raton; New York: CRC Press; 2010. pp. 1\u2013313."}, {"Citation": "Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12\u201313):1217\u20131258.", "ArticleIdList": ["PMC3109627", "11113252"]}, {"Citation": "Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965\u20131976.", "ArticleIdList": ["15194258"]}, {"Citation": "Tuazon CU. Toxoplasmosis in AIDS patients. J Antimicrob Chemother. 1989;23(Suppl A):77\u201382.", "ArticleIdList": ["2654118"]}, {"Citation": "Martins-Duarte ES, Urbina JA, de Souza W, Vommaro RC. Anti-proliferative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitro. J Antimicrob Chemother. 2006;58(1):59\u201365.", "ArticleIdList": ["16702175"]}, {"Citation": "Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12(4):564\u2013582.", "ArticleIdList": ["PMC88925", "10515903"]}, {"Citation": "Yallapu MM, Nagesh PK, Jaggi M, Chauhan SC. Therapeutic applications of curcumin nanoformulations. Aaps J. 2015;17(6):1341\u20131356.", "ArticleIdList": ["PMC4627456", "26335307"]}, {"Citation": "Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci. 2009;30(2):85\u201394.", "ArticleIdList": ["19110321"]}, {"Citation": "Garc\u00eda-Ni\u00f1o WR, Pedraza-Chaverr\u00ed J. Protective effect of curcumin against heavy metals-induced liver damage. Food Chem Toxicol. 2014;69:182\u2013201.", "ArticleIdList": ["24751969"]}, {"Citation": "Bulboac\u0103 AE, Bolboac\u0103 SD, St\u0103nescu IC, et al. The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats. Int J Nanomedicine. 2018;13:3093\u20133103.", "ArticleIdList": ["PMC5975613", "29872296"]}, {"Citation": "Bulboac\u0103 A, Bolboac\u0103 DS, Suci S. Protective effect of curcumin in fructose-induced metabolic syndrome and in streptozotocin-induced diabetes in rats. Iran J Basic Med Sci. 2016;19(6):585\u2013593.", "ArticleIdList": ["PMC4951596", "27482338"]}, {"Citation": "Bulboac\u0103 AE, Bolboac\u0103 SD, St\u0103nescu IC, Sfr\u00e2ngeu CA, Bulboac\u0103 AC. Preemptive analgesic and antioxidative effect of curcumin for experimental migraine. Biomed Res Int. 2017;2017:4754701\u20134754707.", "ArticleIdList": ["PMC5674483", "29204441"]}, {"Citation": "Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014;2014:186864.", "ArticleIdList": ["PMC4022204", "24877064"]}, {"Citation": "Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40\u201359.", "ArticleIdList": ["PMC2637808", "18662800"]}, {"Citation": "Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: biological actions and medicinal applications. Curr Sci. 2004;87:44\u201353."}, {"Citation": "Feng T, Wei Y, Lee RJ, Zhao L. Liposomal curcumin and its application in cancer. Int J Nanomedicine. 2017;12:6027\u20136044.", "ArticleIdList": ["PMC5573051", "28860764"]}, {"Citation": "de Moraes J. Natural products with antischistosomal activity. Future Med Chem. 2015;7(6):801\u2013820.", "ArticleIdList": ["25996071"]}, {"Citation": "Ara\u00fajo CC, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz. 2001;96(5):723\u2013728.", "ArticleIdList": ["11500779"]}, {"Citation": "Koide T, Nose M, Ogihara Y, Yabu Y, Ohta N. Leishmanicidal effect of curcumin in vitro. Biol Pharm Bull. 2002;25(1):131\u2013133.", "ArticleIdList": ["11824543"]}, {"Citation": "Das R, Roy A, Dutta N, Majumder HK. Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani. Apoptosis. 2008;13(7):867\u2013882.", "ArticleIdList": ["18506627"]}, {"Citation": "P\u00e9rez-Arriaga L, Mendoza-Maga\u00f1a ML, Cort\u00e9s-Z\u00e1rate R, et al. Cytotoxic effect of curcumin on Giardia lamblia trophozoites. Acta Trop. 2006;98(2):152\u2013161.", "ArticleIdList": ["16678115"]}, {"Citation": "Nose M, Koide T, Ogihara Y, Yabu Y, Ohta N. Trypanocidal effects of curcumin in vitro. Biol Pharm Bull. 1998;21(6):643\u2013645.", "ArticleIdList": ["9657056"]}, {"Citation": "Nagajyothi F, Zhao D, Weiss LM, Tanowitz HB. Curcumin treatment provides protection against Trypanosoma cruzi infection. Parasitol Res. 2012;110(6):2491\u20132499.", "ArticleIdList": ["PMC3556637", "22215192"]}, {"Citation": "Haddad M, Sauvain M, Deharo E. Curcuma as a parasiticidal agent: a review. Planta Med. 2011;77(6):672\u2013678.", "ArticleIdList": ["21104602"]}, {"Citation": "Flora G, Gupta D, Tiwari A. Nanocurcumin: a promising therapeutic advancement over native curcumin. Crit Rev Ther Drug Carrier Syst. 2013;30(4):331\u2013368.", "ArticleIdList": ["23662605"]}, {"Citation": "Wang S, Su R, Nie S, et al. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem. 2014;25(4):363\u2013376.", "ArticleIdList": ["PMC3959237", "24406273"]}, {"Citation": "Gupta A, Eral HB, Hatton TA, Doyle PS. Nanoemulsions: formation, properties and applications. Soft Matter. 2016;12(11):2826\u20132841.", "ArticleIdList": ["26924445"]}, {"Citation": "Abdel-Hady NM, El-Sherbini GT, Morsy TA. Treatment of Toxoplasma gondii by two Egyptian herbs. J Egypt Soc Parasitol. 2008;38(3):1025\u20131026.", "ArticleIdList": ["19209782"]}, {"Citation": "Al-Zanbagi NA, Zelai NT. Two methods for attenuating Toxoplasma gondii tachyzoites RH strain by using ethanol extract of Curcuma longa. J Egypt Soc Parasitol. 2008;38(3):965\u2013976.", "ArticleIdList": ["19209778"]}, {"Citation": "Teimouri A, Modarressi MH, Shojaee S, et al. Detection of toxoplasma-specific immunoglobulin G in human sera: performance comparison of in house Dot-ELISA with ECLIA and ELISA. Eur J Clin Microbiol Infect Dis. 2018;37(8):1421\u20131429.", "ArticleIdList": ["29737440"]}, {"Citation": "Selseleh M, Modarressi MH, Mohebali M, et al. Real-time RT-PCR on SAG1 and BAG1 gene expression during stage conversion in immunosuppressed mice infected with Toxoplasma gondii Tehran strain. Korean J Parasitol. 2012;50(3):199\u2013205.", "ArticleIdList": ["PMC3428564", "22949746"]}, {"Citation": "Ole A. Manual of diagnostic tests and vaccines for terrestrial animals. Toxoplasmosis. 2008;1(6):1286."}, {"Citation": "Bouchemal K, Brian\u00e7on S, Perrier E, Fessi H. Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. Int J Pharm. 2004;280(1\u20132):241\u2013251.", "ArticleIdList": ["15265563"]}, {"Citation": "Naz Z, Ahmad FJ. Curcumin-loaded colloidal carrier system: formulation optimization, mechanistic insight, ex vivo and in vivo evaluation. Int J Nanomedicine. 2015;10:4293\u20134307.", "ArticleIdList": ["PMC4498720", "26170665"]}, {"Citation": "Teimouri A, Azami SJ, Keshavarz H, et al. Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain. Int J Nanomedicine. 2018;13:1341\u20131351.", "ArticleIdList": ["PMC5849388", "29563791"]}, {"Citation": "Azami SJ, Amani A, Keshavarz H, et al. Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis. Eur J Pharm Sci. 2018;117:138\u2013146.", "ArticleIdList": ["29452213"]}, {"Citation": "Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods. 2001;25(4):402\u2013408.", "ArticleIdList": ["11846609"]}, {"Citation": "Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology: The Essentials. 3rd ed. Baltimore: Williams and Wilkins; 1996."}, {"Citation": "Faucher B, Moreau J, Zaegel O, Franck J, Piarroux R. Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS. J Antimicrob Chemother. 2011;66(7):1654\u20131656.", "ArticleIdList": ["21459896"]}, {"Citation": "Crespo M, Quereda C, Pascual J, Rivera M, Clemente L, Cano T. Patterns of sulfadiazine acute nephrotoxicity. Clin Nephrol. 2000;54(1):68\u201372.", "ArticleIdList": ["10939760"]}, {"Citation": "Djurkovi\u0107-Djakovi\u0107 O, Nikoli\u0107 T, Robert-Gangneux F, Bobi\u0107 B, Nikoli\u0107 A. Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis. Antimicrob Agents Chemother. 1999;43(9):2240\u20132244.", "ArticleIdList": ["PMC89454", "10471572"]}, {"Citation": "Dunay IR, Heimesaat MM, Bushrab FN, et al. Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother. 2004;48(12):4848\u20134854.", "ArticleIdList": ["PMC529229", "15561866"]}, {"Citation": "Hughes LM, Lanteri CA, O\u2019Neil MT, Johnson JD, Gribble GW, Trumpower BL. Design of anti-parasitic and anti-fungal hydroxynaphthoquinones that are less susceptible to drug resistance. Mol Biochem Parasitol. 2011;177(1):12\u201319.", "ArticleIdList": ["PMC5054302", "21251932"]}, {"Citation": "Lahlou M. The success of natural products in drug discovery. Pharmacol Pharm. 2013;4(3):17\u201331."}, {"Citation": "Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21(5):559.", "ArticleIdList": ["PMC6273146", "27136524"]}, {"Citation": "Song P, Zhang R, Wang X, He P, Tan L, Ma X. Dietary grape-seed procyanidins decreased postweaning diarrhea by modulating intestinal permeability and suppressing oxidative stress in rats. J Agric Food Chem. 2011;59(11):6227\u20136232.", "ArticleIdList": ["21534629"]}, {"Citation": "Teimouri A, Haghi AM, Nateghpour M, et al. Antimalarial efficacy of low molecular weight chitosan against Plasmodium berghei infection in mice. J Vector Borne Dis. 2016;53(4):312\u2013316.", "ArticleIdList": ["28035107"]}, {"Citation": "Wang J, Han M, Zhang G, Qiao S, Li D, Ma X. The signal pathway of antibiotic alternatives on intestinal microbiota and immune function. Curr Protein Pept Sci. 2016;17(8):785\u2013796.", "ArticleIdList": ["27226197"]}, {"Citation": "Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem. 2007;102(4):1095\u20131104.", "ArticleIdList": ["17472706"]}, {"Citation": "Vogel A, Pelletier J. Examen chimique de la racine de Curcuma. [Chemical review of tuemric root] J Pharm. 1815;1:289\u2013300. French."}, {"Citation": "Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012;39(3):283\u2013299.", "ArticleIdList": ["PMC3288651", "22118895"]}, {"Citation": "Loeber CC. De Curcuma officinarum. [The curcuma factories] diss Inaug Halae. 1748 Latin."}, {"Citation": "Oppenheimer A. Turmeric (curcumin) in biliary diseases. Lancet. 1937;229(5924):619\u2013621."}, {"Citation": "Rasmussen HB, Christensen SB, Kvist LP, Karazmi A. A simple and efficient separation of the curcumins, the antiprotozoal constituents of Curcuma longa. Planta Med. 2000;66(4):396\u2013398.", "ArticleIdList": ["10865470"]}, {"Citation": "Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN. Curcumin for malaria therapy. Biochem Biophys Res Commun. 2005;326(2):472\u2013474.", "ArticleIdList": ["15582601"]}, {"Citation": "Cui L, Miao J, Cui L. Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob Agents Chemother. 2007;51(2):488\u2013494.", "ArticleIdList": ["PMC1797756", "17145789"]}, {"Citation": "Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumincellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2004;44(2):97\u2013111.", "ArticleIdList": ["15116757"]}, {"Citation": "Wahlstr\u00f6m B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol. 1978;43(2):86\u201392.", "ArticleIdList": ["696348"]}, {"Citation": "Bhawana, Basniwal RK, Buttar HS, Jain VK, Jain N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem. 2011;59(5):2056\u20132061.", "ArticleIdList": ["21322563"]}, {"Citation": "Dandekar PP, Jain R, Patil S, et al. Curcumin-loaded hydrogel nanoparticles: application in anti-malarial therapy and toxicological evaluation. J Pharm Sci. 2010;99(12):4992\u20135010.", "ArticleIdList": ["20821383"]}, {"Citation": "Akhtar F, Rizvi MM, Kar SK. Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnol Adv. 2012;30(1):310\u2013320.", "ArticleIdList": ["21619927"]}, {"Citation": "Lovelyn C, Attama AA. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol. 2011;2(5):626\u2013639."}, {"Citation": "Hernandez-Jaimes C, Fouconnier B, Perez-Alonso C, Mungu\u0131a-Guillen JL, Vernon-Carter EJ. Degradation activity: formulation optimization, characterization, and stability of Equisetum arvense extract nanoemulsion. J Disper Sci Technol. 2013;34:64\u201371."}, {"Citation": "Lu PS, Inbaraj BS, Chen BH. Determination of oral bioavailability of curcuminoid dispersions and nanoemulsions prepared from Curcuma longa Linnaeus. J Sci Food Agric. 2018;98(1):51\u201363.", "ArticleIdList": ["28516478"]}, {"Citation": "Park HJ, Kong M. Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier. Carbohydr Polym. 2011;83:1303\u20131310."}, {"Citation": "Rachmawati H, Budiputra DK, Mauludin R. Curcumin nanoemulsion for transdermal application: formulation and evaluation. Drug Dev Ind Pharm. 2015;41(4):560\u2013566.", "ArticleIdList": ["24502271"]}, {"Citation": "Villalobos MC, Serradilla MJ, Mart\u00edn A, Ordiales E, Ruiz-Moyano S, C\u00f3rdoba MG. Antioxidant and antimicrobial activity of natural phenolic extract from defatted soybean flour by-product for stone fruit postharvest application. J Sci Food Agric. 2016;96(6):2116\u20132124.", "ArticleIdList": ["26133536"]}, {"Citation": "Nakashima H, Okubo K, Honda Y, Tamura T, Matsuda S, Yamamoto N. Inhibitory effect of glycosides like saponin from soybean on the infectivity of HIV in vitro. AIDS. 1989;3(10):655\u2013658.", "ArticleIdList": ["2574582"]}, {"Citation": "Naim M, Gestetner B, Zilkah S, Birk Y, Bondi A. Soybean isoflavones. Characterization, determination, and antifungal activity. J Agric Food Chem. 1974;22(5):806\u2013810.", "ArticleIdList": ["4472691"]}, {"Citation": "Dahbi A, Bellete B, Flori P, et al. The effect of essential oils from Thymus broussonetii Boiss on transmission of Toxoplasma gondii cysts in mice. Parasitol Res. 2010;107(1):55\u201358.", "ArticleIdList": ["20336317"]}]}], "History": [{"Year": "2018", "Month": "12", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["30519020", "PMC6233476", "10.2147/IJN.S181896", "ijn-13-7363"]}}]}